Only show
results for:

Topics related to "Examine Therapeutic Monoclonal"

monoclonal antibody
monoclonal antibody an antibody that is mass produced in the laboratory from a single clone and that recognizes only one antigen. Monoclonal antibodies are typically made by fusing a normally short-lived, antibody-producing B cell (see immunity ) to a fast-growing cell, such as a cancer cell (some... Read more
Georges Jean Franz Köhler
Georges Jean Franz Köhler , 1946-95, German immunologist, Ph.D. Univ. of Freiburg, 1974. He worked (1974-76) with César Milstein at the Laboratory of Molecular Biology in Cambridge, England. There they developed a practical technique for mass-producing monoclonal antibodies by fusing... Read more
antibody
antibody protein produced by the immune system (see immunity ) in response to the presence in the body of antigens: foreign proteins or polysaccharides such as bacteria, bacterial toxins , viruses, or other cells or proteins. Such antigens are capable of inflicting damage by chemically combining ... Read more
medicine
medicine the science and art of treating and preventing disease. History of Medicine Ancient Times Prehistoric skulls found in Europe and South America indicate that Neolithic man was already able to trephine, or remove disks of bone from, the skull successfully, but whether this del... Read more
biotechnology
biotechnology the use of biological processes, as through the exploitation and manipulation of living organisms or biological systems, in the development or manufacture of a product or in the technological solution to a problem. As such, biotechnology is a general category that has applications in ... Read more
non-Hodgkin's lymphoma
non-Hodgkin's lymphoma any cancer of the lymphoid tissue (see lymphatic system ) in which the Reed-Sternberg cells characteristic of Hodgkin's disease (the other category of lymphoma) are not present. There are about 10 different types of non-Hodgkin's lymphomas, some slower- or faster-growing t... Read more
genetic engineering
genetic engineering the use of various methods to manipulate the DNA (genetic material) of cells to change hereditary traits or produce biological products. The techniques include the use of hybridomas (hybrids of rapidly multiplying cancer cells and of cells that make a desired antibody) to make ... Read more
leukemia
leukemia , cancerous disorder of the blood-forming tissues (bone marrow, lymphatics, liver, spleen) characterized by excessive production of immature or mature leukocytes (white blood cells; see blood ) and consequently a crowding-out of red blood cells and platelets. It was first named by Rudolf ... Read more
immunity
immunity ability of an organism to resist disease by identifying and destroying foreign substances or organisms. Although all animals have some immune capabilities, little is known about nonmammalian immunity. Mammals are protected by a variety of preventive mechanisms, some of them nonspecific (e.... Read more
infectious mononucleosis
infectious mononucleosis , acute infectious disease of older children and young adults, occurring sporadically or in epidemic form, also known as mono, glandular fever, and kissing disease. The causative organism is a herpesvirus known as Epstein-Barr virus . The disease occurs most often in patien... Read more

Related newspaper, magazine, and trade journal articles from HighBeam Research

Examine Therapeutic Monoclonal Antibodies Market.
News Wire article from: Internet Wire; 10/6/2008; 700+ words ; ...available in its catalogue. Therapeutic Monoclonal Antibodies Report 2008...reportlinker.com/p096392/Therapeutic-Monoclonal-Antibodies-Report...investigates the global market for therapeutic monoclonal antibodies. While the pharmaceutical...
IGEN Launches M-SERIES(R) Application to Facilitate Development Of Monoclonal Antibody Therapies.
PR Newswire; 10/15/2002; 700+ words ; ...The total market for therapeutic monoclonal antibodies is a multibillion...development programs. Monoclonal antibodies are currently...life science companies examine monoclonal antibodies as potential therapeutic candidates and develop...
Research and Markets: European mAbs Market Holds Both Promise and Pitfalls.
Business Wire; 3/11/2009; 700+ words ; ...an overview of therapeutic monoclonal antibodies together...analysts thoroughly examine the following therapeutic monoclonal antibody (mAbs...analysts thoroughly examine the following...4 EUROPEAN THERAPEUTIC MONOCLONAL ANTIBODY MARKET...
European mAbs Market Holds Both Promise and Pitfalls.
M2 Presswire; 3/11/2009; 700+ words ; ...an overview of therapeutic monoclonal antibodies together...analysts thoroughly examine the following therapeutic monoclonal antibody (mAbs...analysts thoroughly examine the following...4 EUROPEAN THERAPEUTIC MONOCLONAL ANTIBODY MARKET...
European mAbs Market Holds Both Promise and Pitfalls.(Industry overview)(Report)
Newspaper article from: Blood Weekly; 3/26/2009; 700+ words ; ...titled European Therapeutic Monoclonal Antibody Markets provides an overview of therapeutic monoclonal antibodies together with...expert analysts thoroughly examine the following therapeutic monoclonal antibody (mAbs) markets...
Monoclonal Antibody Therapeutics.
M2 Presswire; 8/10/2009; 700+ words ; ...report By ordering Monoclonal Antibody Therapeutics...prognosis for the global monoclonal antibody therapeutics...disorders and other therapeutic areas from 2009 to...analyses for leading monoclonal antibodies, including...transcripts provided * Examine strengths, weakness...
Product Briefs.
Newspaper article from: Medical Device Daily; 10/16/2002; 700+ words ; ...cell culture product lines. Monoclonal antibodies are widely used in therapeutic, diagnostic and research applications...process as life science companies examine monoclonal antibodies as potential therapeutic candidates and develop proprietary...
Research issues for the introduction of monoclonal antibody technology into health care. (NEWS ADVISORY)
PR Newswire; 7/13/1989; 700+ words ; ...INTRODUCTION OF MONOCLONAL ANTIBODY TECHNOLOGY...and the FDA will examine a variety of issues...commercialization of monoclonal antibody delivery...as diagnostic or therapeutic agents in healthcare. Several monoclonal antibody-based...
Reportlinker Adds Monoclonal Antibody Therapeutics 2009-2024.
Business Wire; 9/30/2009; 700+ words ; ...report By ordering Monoclonal Antibody Therapeutics...prognosis for the global monoclonal antibody therapeutics...disorders and other therapeutic areas from 2009 to...analyses for leading monoclonal antibodies, including...transcripts provided * Examine strengths, weakness...
Progenics Reports Positive Results from Phase 1 Clinical Trial of PRO 140, a Novel Monoclonal Antibody That Blocks HIV Entry; Single Dose Coats Immune Cells for Two Months, Potential Long-Acting HIV Therapy.
Business Wire; 9/9/2005; 700+ words ; ...is a humanized monoclonal antibody against...represents an important therapeutic target. The announcement...was the first to examine the effects of this humanized monoclonal antibody in humans...for the potential therapeutic effects of PRO...